TABLE 1.
Antimicrobial resistance phenotypes of S. sonnei isolates by PFGE type
| PFGE type | No. of isolates | Antimicrobial resistance phenotypea
|
|||||
|---|---|---|---|---|---|---|---|
| AMP | STREP | SUL | TET | TRIM | NAL | ||
| A | 51b | R | R | R | S | S | S |
| A | 1b,c | R | S | S | S | S | S |
| A | 1b,d | R | S | R | S | R | S |
| B | 11b | S | R | R | R | R | S |
| B | 1b,e | R | R | R | R | R | S |
| B | 1b,f | S | R | R | R | R | R |
| B | 1b,g | S | R | S | S | R | S |
a
AMP, ampicillin; STREP, streptomycin; SUL, sulfonamide; TET, tetracycline, TRIM, trimethoprim; NAL, nalidixic acid; R, resistance; S, susceptible.
b
In addition, all isolates were susceptible to chloramphenicol, ciprofloxacin, kanamycin, and nitrofurantoin.
c
Isolate 3599.
d
Isolate 3219.
e
Isolates CK2.
f
Isolate 1778.
g
Isolate CK1.